OUR CLIENTS INCLUDE:

Aastrom Biosciences
Abbott Vascular
ActivBiotics
AngioScore
ANS (St. Jude Medical)
Bain & Company
BioMarin Pharmaceutical
Boston Scientific
Cordis (Johnson & Johnson Pharmaceuticals)
Cook Medical
Diffusion Pharmaceuticals LLC
Diomed Inc.
Edwards Lifesciences
ev3
FoxHollow Technologies
GlaxoSmithKline
Harvest Technologies
IDev Technologies
Indigo Pharmaceuticals
Joan Piesinger & Associates
Kerberos Proximal Solution
King Pharmaceuticals
Medtronic
Nuvelo Inc.
OmniSonics Medical Technologies
Pathway Medical Technologies
Possis Medical
Rapid Medical
Sanofi-Aventis
Schering-Plough Corp.
Solvay Pharmaceuticals
Spectranetics Corporation
Stereotaxis
Terumo
The Medicines Company
Thermogenesis Corp.
ThromboGenics Ltd.
W. L. Gore

According to
THE SAGE GROUP:

The prevalence of peripheral artery disease (PAD) in the U.S. is much higher than the commonly cited figures of 8-12 million.

Research published by THE SAGE GROUP indicates that 16.5 million people in the U.S. had PAD in 2007. With the ageing population, this number is projected to exceed 22 million by 2020.